Best Practice & Research Clinical Haematology
Volume 22, Issue 3 , Pages 283-284 , September 2009

Introduction: CML in the imatinib era

  • R. Hehlmann (Professor Dr. med.)

      Affiliations

    • Corresponding Author InformationTel.: +49 621 383 6931; Fax: +49 621 383 6932.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1521-6926(09)00072-3

doi: 10.1016/j.beha.2009.10.002

Best Practice & Research Clinical Haematology
Volume 22, Issue 3 , Pages 283-284 , September 2009

Article Tools

* Image Usage & Resolution